Propafenone Extended Release Capsule and Zyprexa Zydis
Determining the interaction of Propafenone Extended Release Capsule and Zyprexa Zydis and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using OLANZapine together with propafenone can increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may be more susceptible if you have a heart condition called congenital long QT syndrome, other cardiac diseases, conduction abnormalities, or electrolyte disturbances (for example, magnesium or potassium loss due to severe or prolonged diarrhea or vomiting). Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with these medications, whether together or alone. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: It is uncertain whether olanzapine causes clinically significant prolongation of the QT interval. In pooled studies of adults as well as pooled studies of adolescents, there were no significant differences between olanzapine and placebo in the proportion of patients experiencing potentially important changes in ECG parameters, including QT, QTcF (Fridericia-corrected), and PR intervals. In clinical trials, clinically meaningful QTc prolongations (QTcF >=500 msec at any time post-baseline in patients with baseline QTcF
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Zyprexa (olanzapine)." Lilly, Eli and Company, Indianapolis, IN.
Generic Name: propafenone
Brand name: Rythmol, Rythmol SR
Synonyms: Propafenone
Generic Name: olanzapine
Brand name: Zyprexa, Zyprexa Zydis, Zyprexa Intramuscular, Zyprexa Relprevv
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Propafenone Extended Release Capsule-Zyrtec
- Propafenone Extended Release Capsule-Zyrtec (Cetirizine Capsules and Tablets)
- Propafenone Extended Release Capsule-Zyrtec (Cetirizine Chewable Tablets)
- Propafenone Extended Release Capsule-Zyrtec (Cetirizine Orally Disintegrating Tablets)
- Propafenone Extended Release Capsule-Zyrtec (Cetirizine Syrup)
- Propafenone Extended Release Capsule-Zyrtec Capsule
- Zyprexa Zydis-Propafenone Hydrochloride
- Zyprexa Zydis-Propafenone Sustained-Release Capsules
- Zyprexa Zydis-Propafenone Tablets
- Zyprexa Zydis-Propantheline
- Zyprexa Zydis-Propantheline Bromide
- Zyprexa Zydis-Propecia